Synthetic biology (SynBio) has grown over the last two decades to emerge as a mature area in biological engineering with its potential to offer innovative applications across various industries including healthcare and consumer. 

GlobalData’s FutureTech Series, ‘Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio Revolution?’ reveals that the key focus of enterprises is to partner with innovative SynBio companies to create new biological products, including bioplastics and biochemicals that can replace harmful synthetics. 

Incumbents from different industries are exercising collaborative projects, acquisition initiatives, merging business divisions, and licensing new technologies to investigate the potential of SynBio in their domains.  

Multinational fashion house Lululemon identifies the replacement of leather with sustainable alternatives, whereas agro giant ADM seeks the replacement of chemical fertilizers. Bio instrument manufacturer Bio-RAD investigates advanced analytics into gene editing, while chemical leader BASF focuses on biochemicals. 

The report highlights the importance of SynBio in the design and creation of biological entities that do not exist in nature or reengineer existing biological systems to develop products like medicines, chemicals, ingredients, and advanced materials to revolutionize the way we live and build a sustainable economy. 

To know more, request a free sample of the report here: https://bit.ly/3D3h28N